Autolus Therapeutics
Entity

  • Autolus Therapeutics

    Created in 2014
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    26,562

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    The MediaWorks, 191 Wood Ln, London W12 7FP, UK

    London

    United Kingdom

  • Employees

    Scale: 501-1000

    Estimated: 643

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    8 months, 3 weeks ago
Description
  • Value proposition

    Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer

    Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.

  • Autolus - developing CAR T cell therapies for cancer patients

    Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver life-changing benefits to cancer patients.

    • https://www.autolus.com
  • Website is disabled or domain is for sale
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics